Indeed, it turned out that in MTC patients of our study group, the absence of any variant in RET, besides i14 rs2472737, was a factor that protected against the development of MTC at a younger age (p = 0.0234, statistical power = 76.67%). Here, RET is linked to medullary thyroid gland carcinoma.